The Valley Desk

Clinical trial reportJAMA oncologyPublished

PDS0101 With Pembrolizumab in HPV16-Positive Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma: A Phase 2 Nonrandomized Clinical Trial

Read the publication ↗ Open access copy ↗

Regional connection

Verified An author affiliation on the Europe PMC record names Fox Chase Cancer Center, with Temple Health linked by the institution reference. Affiliation source

Publication record

Type
Clinical trial report
Venue
JAMA oncology
Published
Subject terms
Humans; Papillomavirus Infections; Head and Neck Neoplasms; Neoplasm Recurrence, Local; Antineoplastic Combined Chemotherapy Protocols; Adult; Aged; Middle Aged; Female; Male; Human papillomavirus 16; Antibodies, Monoclonal, Humanized
PubMed ID
42752531
PubMed Central ID
PMC13586970
Open access
Yes, open
Added to directory
Source checked

Report a correction or request removal